Cargando…

Correction to: Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort

Detalles Bibliográficos
Autores principales:	Liu, Yi, Tan, Meng-Shan, Wang, Zuo-Teng, Xu, Wei, Tan, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935798/ https://www.ncbi.nlm.nih.gov/pubmed/35313856 http://dx.doi.org/10.1186/s12883-022-02616-2

Ejemplares similares

Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort
por: Liu, Yi, et al.
Publicado: (2022)

MAPT rs242557 variant is associated with hippocampus tau uptake on (18)F-AV-1451 PET in non-demented elders
por: Shen, Xue-Ning, et al.
Publicado: (2019)

P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders
por: Ma, Ling-Zhi, et al.
Publicado: (2021)

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
por: Guo, Yu, et al.
Publicado: (2021)

Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort
por: Cong, Wang, et al.
Publicado: (2017)

Impact of SORL1 genetic variations on MRI markers in non-demented elders
por: Yin, Rui-Hua, et al.
Publicado: (2016)

Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI
por: Windon, Charles, et al.
Publicado: (2022)

Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders
por: Dou, Kai-Xin, et al.
Publicado: (2019)

CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease
por: Hunt, Aoife, et al.
Publicado: (2006)

Intensive naming training for low-educated demented and non-demented elderly
por: Ferreira, Amanda Cristina de Souza, et al.
Publicado: (2020)

Correction: APOE Status Modulates the Changes in Network Connectivity Induced by Brain Stimulation in Non-Demented Elders
por: Peña-Gomez, Cleofé, et al.
Publicado: (2013)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
por: Ben Bouallègue, Fayçal, et al.
Publicado: (2017)

Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort
por: Chen, Dandan, et al.
Publicado: (2023)

Genome-wide association study identifies CD1A associated with rate of increase in plasma neurofilament light in non-demented elders
por: Wang, Zuo-Teng, et al.
Publicado: (2019)

Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders
por: Li, Jie-Qiong, et al.
Publicado: (2020)

Genome-wide association study of hippocampal atrophy rate in non-demented elders
por: Guo, Yu, et al.
Publicado: (2019)

Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
por: Biel, Davina, et al.
Publicado: (2021)

Zero Echo Time MRAC on FDG-PET/MR Maintains Diagnostic Accuracy for Alzheimer’s Disease; A Simulation Study Combining ADNI-Data
por: Ando, Takahiro, et al.
Publicado: (2020)

Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study
por: Okada, Yusuke, et al.
Publicado: (2019)

A Novel Deep Learning Radiomics Model to Discriminate AD, MCI and NC: An Exploratory Study Based on Tau PET Scans from ADNI †
por: Zhao, Yan, et al.
Publicado: (2022)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
por: Goldhardt, Oliver, et al.
Publicado: (2019)

Anticonvulsants in the treatment of aggression in the demented elderly: an update
por: Amann, Benedikt, et al.
Publicado: (2009)

Hypoperfusion Precedes Tau Deposition in the Entorhinal Cortex: A Retrospective Evaluation of ADNI-2 Data
por: Kapadia, Anish, et al.
Publicado: (2023)

Generation of Conventional (18)F-FDG PET Images from (18)F-Florbetaben PET Images Using Generative Adversarial Network: A Preliminary Study Using ADNI Dataset
por: Choi, Hyung Jin, et al.
Publicado: (2023)

Patterns of CSF Inflammatory Markers in Non-demented Older People: A Cluster Analysis
por: Peng, Yangdi, et al.
Publicado: (2020)

Correction: Abolishing Tau cleavage by caspases at Aspartate(421) causes memory/synaptic plasticity deficits and pre-pathological Tau alterations
por: Biundo, F., et al.
Publicado: (2018)

Correction: Grey Matter Correlates of Three Language Tests in Non-demented Older Adults
por: Zhang, Haobo, et al.
Publicado: (2014)

A voxel-based morphometry comparison of the 3.0T ADNI-1 and ADNI-2 volumetric MRI protocols
por: Brunton, Simon, et al.
Publicado: (2015)

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
por: Leuzy, Antoine, et al.
Publicado: (2019)

The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer’s diseases— A simulation study combining multi-center data and ADNI-data
por: Sekine, Tetsuro, et al.
Publicado: (2020)

β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3
por: Bourgeat, Pierrick, et al.
Publicado: (2022)

Association of plasma P-tau181 with memory decline in non-demented adults
por: Therriault, Joseph, et al.
Publicado: (2021)

Matemática demente /
por: Carroll, Lewis, 1832-1898
Publicado: (1983)

Matemática demente /
por: Carroll, Lewis, 1832-1898
Publicado: (1975)

The Dement in the Community
por: Addis, R. S.
Publicado: (1960)

Dementing Prions
por: Mahler, Robert
Publicado: (1996)

Correction: Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
Publicado: (2018)

Correction: Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
por: Asanad, Samuel, et al.
Publicado: (2020)

Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
por: Smith, Ruben, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gol44hrd4bpem212b1ehl0t78q